Cargando…

Gut microbiome alters functions of mutant p53 to promote tumorigenesis

Detalles Bibliográficos
Autores principales:	Lau, Harry Cheuk Hay, Yu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547703/ https://www.ncbi.nlm.nih.gov/pubmed/33037184 http://dx.doi.org/10.1038/s41392-020-00336-y

Ejemplares similares

Targeted prebiotics alter the obese gut microbiome in humans
por: She, Junjun, et al.
Publicado: (2021)

Microbiota-mediated phytate metabolism activates HDAC3 to contribute intestinal homeostasis
por: Li, Xiaoxing, et al.
Publicado: (2020)

A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis
por: Yue, Xuetian, et al.
Publicado: (2016)

Gut Microbiome in Colorectal Cancer: Clinical Diagnosis and Treatment
por: Liu, Yali, et al.
Publicado: (2023)

BAG2 promotes tumorigenesis through enhancing mutant p53 protein levels and function
por: Yue, Xuetian, et al.
Publicado: (2015)

Microbial metabolites in colorectal tumorigenesis and cancer therapy
por: Liu, Yali, et al.
Publicado: (2023)

The arsenal of TP53 mutants therapies: neoantigens and bispecific antibodies
por: Yang, Chang, et al.
Publicado: (2021)

The Gain of Function of p53 Mutant p53S in Promoting Tumorigenesis by Cross-talking with H-RasV12
por: Jia, Shuting, et al.
Publicado: (2012)

Spliced MDM2 isoforms promote mutant p53 accumulation and gain-of-function in tumorigenesis
por: Zheng, Tongsen, et al.
Publicado: (2013)

Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis
por: Stein, Yan, et al.
Publicado: (2019)

Population dynamics of the human gut microbiome: change is the only constant
por: Priya, Sambhawa, et al.
Publicado: (2019)

The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic
por: Kadosh, Eliran, et al.
Publicado: (2020)

A P4 Medicine Perspective of Gut Microbiota and Prediabetes: Systems Analysis and Personalized Intervention
por: Huang, Qiongrong, et al.
Publicado: (2020)

Microbiota's 'little helpers': bacteriophages and antibiotic-associated responses in the gut microbiome
por: Sun, Christine L, et al.
Publicado: (2013)

We are what we eat: how the diet of infants affects their gut microbiome
por: Pop, Mihai
Publicado: (2012)

Microbiomes as the new keystone for life sciences development
por: Udaondo, Zulema, et al.
Publicado: (2019)

Blood group-gut microbiome—health axis gains further support from landmark multi-omics study in swines
por: Wang, Jiejing, et al.
Publicado: (2022)

Uncovering novel human gut virome using ultra-deep metagenomic sequencing
por: Lau, Harry Cheuk Hay, et al.
Publicado: (2022)

Gut microbiota: in sickness and in health
por: Huertas, M José, et al.
Publicado: (2014)

CNMa–CNMa receptor at microbiome–gut–brain axis: novel target to regulate feeding decision
por: Peng, Liyuan, et al.
Publicado: (2021)

Non‐zero‐sum microbiome immune system interactions [Image: see text]
por: Tuganbaev, Timur, et al.
Publicado: (2021)

p53-induced inflammation links heart failure with insulin resistance
Publicado: (2012)

New tricks for p53 regulation – restraint by protein coding RNAs
por: Blattner, Christine
Publicado: (2015)

The microbiota–gut–brain axis regulates motivation for exercise
por: Sun, Wenhuan, et al.
Publicado: (2023)

Harness the functions of gut microbiome in tumorigenesis for cancer treatment
por: Lee, Mong‐Hong
Publicado: (2021)

Targeting the Gut Microbiota in Coronavirus Disease 2019: Hype or Hope?
por: Lau, Harry Cheuk-Hay, et al.
Publicado: (2022)

Gut microbiota: impacts on gastrointestinal cancer immunotherapy
por: Lau, Harry Cheuk Hay, et al.
Publicado: (2021)

A good gut feeling on Sarm1-mediated axon degeneration
por: von Saucken, Victoria E., et al.
Publicado: (2021)

Intestinal homeostasis and inflammation: Gut microbiota at the crossroads of pancreas–intestinal barrier axis
por: Zhang, Zhongwei, et al.
Publicado: (2022)

Heterozygous inactivation of tsc2 enhances tumorigenesis in p53 mutant zebrafish
por: Kim, Seok-Hyung, et al.
Publicado: (2013)

Ubiquitin ligase TRIM71 suppresses ovarian tumorigenesis by degrading mutant p53
por: Chen, Yajie, et al.
Publicado: (2019)

The Gut Microbiome Modulates Colon Tumorigenesis
por: Zackular, Joseph P., et al.
Publicado: (2013)

Alterations of the Gut Microbiome and Fecal Metabolome in Colorectal Cancer: Implication of Intestinal Metabolism for Tumorigenesis
por: Du, Xinhao, et al.
Publicado: (2022)

The volatile microbiome
por: Weinstock, George M
Publicado: (2011)

Highlight: Changing the Canon—Revisiting a Classic Experiment to Alter the Genetic Code
por: Venton, Danielle
Publicado: (2014)

A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
por: Pang, Xiufeng, et al.
Publicado: (2016)

Optimizing the treatment of BRAF mutant melanoma
por: Settleman, Jeff
Publicado: (2014)

Mutant huntingtin in the hypothalamus causes metabolic dysfunction
Publicado: (2011)

Plasma pTau181 as a biomarker for Alzheimer's disease
por: Meng, Jie, et al.
Publicado: (2020)

A gating mechanism of K2P channels by their selectivity filter
por: Yang, Fan
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2tr4okebdhtag8iigikkjdacpk